Laboratory diagnosis and antibiotic susceptibilities of nontuberculous mycobacteria;Tüberküloz dιşι mikobakterilerin laboratuvar tanιsι ve antibiyotik duyarlιlιklarι

Mikrobiyoloji Bulteni

Volumn 39, Issue 1, 2005, Pages 125-132

  Ergin, Alper ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Antibiotic susceptibility; Laboratory diagnosis; Non tuberculous mycobacteria

Indexed keywords

ATYPICAL MYCOBACTERIOSIS; ATYPICAL MYCOBACTERIUM; DRUG EFFECT; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; REVIEW;

ENVIRONMENTAL MICROBIOLOGY; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIA, ATYPICAL; MYCOBACTERIUM INFECTIONS, ATYPICAL;

EID: 33646906243     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Hornick DB, Schlesinger LS: Mycobacteriosis other than tuberculosis, p.420-437. In: Topley and Wilson's Microbiology and Microbial Infections. 1998, 9th ed. Oxford University Press, NY
2. Somoskovi A, Mester J, Hale YM, Parsons LM, Salfinger M: Laboratory diagnosis of nontuberculous mycobacteria. Clin Chest Med 2003, 23: 585-597.
3. Good RC, Shinnick TM: Mycobacterium, p.549-576. In: Topley and Wilson's Microbiology and Microbial Infections 1998, 9th ed. Oxford University Press, NY.
4. Brown-Elliott BA, Griffith DE, Wallace RJ: Newly described or emerging human species of nontuberculous mycobacteria. Infect Dis Clin North Am 2002, 1: 187-220.
5. Saiman L: The mycobacteriology of non-tuberculous mycobacteria. Ped Res Rev 2004, 5: S221-S223.
6. Olivier KN: The natural history of nontuberculous mycobacteria in patients with cystic fibrosis. Ped Res Rev 2004, 5: S213-S216.
7. Catanzaro A: Diagnosis, differentiating colonization, infection and disease. Clin Chest Med 2002, 23: 599-601.
8. American Thoracic Society: Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Res Crit Care Med 1997,156:S1-S25.
9. Griffith DE, Brown-Elliott BA, Wallace RJ: Diagnosing nontuberculous mycobacterial lung disease. Infect Dis Clin North America 2002, 16: 235-249.
10. National Committee for Clinical Laboratory Standards: Susceptibility testing of Mycobacteria, Nocardiae, and other aerobic Actinomycetes: Approved Standard, 2003, 1st ed. M24-A. NCCLS, Wayne, Philadelphia.
11. Brown BA, Wallace RJ: Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev 2002, 15: 716-746.
12. Wolinsky E: Mycobacteria, p. 647-664. In: Davis, Dulbecco (eds), Microbiology. 1990, 4th ed. Lippincott Company, Philadelphia.
13. Metchock B, Nolte FS, Wallace JRJ: Mycobacterium, p. 399-437. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (eds), Manual of Clinical Microbiology. 1999, 7th ed. ASM Press, Washington DC.
14. Ebert DL, Olivier KN: Nontuberculous mycobacteria in cystic fibrosis. Infect Dis Clin North Am 2002, 16:221-233.
15. Brown BA, Wallace RJ: Infections due to nontuberculous mycobacteria, p. 2630-2636. In: Mandell, Bennet, Dolin (eds), Principles and Practice of Infectious Diseases. 2000, 5th ed. Churchill Livingstone, Philadelphia.
16. Katoch VM: Infections due to non-tuberculous mycobacteria (NTM). Indian J Med Res 2004. 120: 290-304.
17. Koneman EW, Ellen SD, Janda WM, Schreckenberger PC, Winn WC (eds): Mycobacteria, p. 893-952. In: Diagnostic Microbiology. 1997, 5th ed. Lippincott Company, Philadelphia.
18. Picardeau M, Prod'Hom G, Raskine L, et al: Genotypic characterization of five subspecies of Mycobacterium kansasii. J Clin Microbiol 1997, 35: 25-32.
19. Kellogg JA, Bankert DA, Withers GS, et al: Application of the Sherlock mycobacteria identification system using high-performance liquid chromatography in a clinical laboratory. J Clin Microbiol 2001, 39: 964-970.
20. Suffys PN, da Silva Rocha A, de Oliveira M, et al: Rapid identification of mycobacteria to the species level using INNO-LiPA Mycobacteria, a reverse hybridization assay. J Clin Microbiol 2001, 39: 4477-4482.
21. Telenti A, Andersen AB, Balz M, et al: Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol 1993, 31: 175-178.
22. Vaneechoutte M, de Beenhouwer H, Claeys G, et al: Identification of Mycobacterium species using amplified ribosomal DNA restriction analysis. J Clin Microbiol 1993, 31: 2061-2065.
23. Ergin A, Kocagöz T, Us D: Evaluation of 120 mycobacterial strains isolated from clinical specimens to the species level by polymerase chain reaction-restriction enzyme analysis. Scand J Infect Dis 2000, 32: 657-662.
24. Ergin A, Hasgelik G: Non tuberculous mycobacteria (NTM) in patients with underlying diseases: Results obtained by using polymerase chain reaction-restriction enzyme analysis between 1997-2002. New Microbiol 2004, 27: 49-53.
25. McNabb A, Eisler D, Adie K, et al: Assessment of partial sequencing of the 65-kilodalton heat shock protein gene (hsp65) for routine identification of Mycobacterium species isolated from clinical sources. J Clin Microbiol 2004, 42: 3000-3011.
26. Inderlied CB: Microbiology and minimum inhibitory concentration testing for Mycobacterium avium complex prophylaxis. Am J Med 1997, 102: 2-10.
27. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: Approved Standard, 2003, 6th ed. M7-A6. NCCLS, Wayne, Philadelphia.
28. Wallace RJ, Brown-Elliott BA, Ward SC, Crist CJ, Mann LB, Wilson RW: Activities of linezolid against rapidly growing mycobacteria. Antimicrob Agent Chemother 2001, 45: 764-767.
29. Koontz FP, Meridith EE, Barrett MS, Jones RN: Etest for routine clinical antimicrobial susceptibility testing of rapid-growing mycobacteria isolates. Diagn Microbiol Infect Dis 1994, 19: 183-186.
30. Flynn CM, Kelley CM, Barrett MS, Jones RN: Application of the Etest to the antimicrobial susceptibility testing of Mycobacterium marinum clinical isolates. J Clin Microbiol 1997, 35: 2083-2086.
31. Woods GL, Bergmann JS, Witebsky FG, et al: Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae and Mycobacterium fortuitum. J Clin Microbiol 1999, 37: 1676-1682.
32. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial susceptibility testing. 11th informational supplement M100-S11, 2002. NCCLS, Wayne, Philadelphia.